SCOPUS 정보 검색 플랫폼

Volumn 120, Issue 6, 2001, Pages 1330-1338

An engineered human antibody to TNF (CDF571) for active Crohn's disease: A randomized double-blind placebo-controlled trial

(14) Sandborn, William J a Feagan, Brian G b Hanauer, Stephen B c Present, Daniel H d Sutherland, Lloyd R e Kamm, Michael A f Wolf, Douglas C g Baker, Jeffrey P h Hawkey, Christopher i Archambault, Andre j Bernstein, Charles N k Novak, Claire l Heath, Patricia K l Targan, Stephan R m

a MAYO CLINIC (United States)

b UNIVERSITY OF WESTERN ONTARIO (Canada)

c UNIVERSITY OF CHICAGO (United States)

d MOUNT SINAI SCHOOL OF MEDICINE (United States)

e UNIVERSITY OF CALGARY (Canada)

f ST MARK S HOSPITAL (United Kingdom)

g Atlanta Gastroenterology Associates (United States)

h UNIVERSITY OF TORONTO (Canada)

i NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035053968 PISSN: 00165085 EISSN: None Source Type: Journal
DOI: 10.1053/gast.2001.24042 Document Type: Article

Times cited : (275)

References (15)

1
- 0025912981
- Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease
- (1991) Gut , vol.32 , pp. 913-917
- Murch, S.H.¹ Lamkin, V.A.² Savage, M.O.³ Walker-Smith, J.A.⁴ MacDonald, T.T.⁵

2
- 0027486125
- Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease
- (1993) Gut , vol.34 , pp. 1705-1709
- Murch, S.H.¹ Braegger, C.P.² Walker-Smith, J.A.³ MacDonald, T.T.⁴

3
- 0026531017
- Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
- (1992) Lancet , vol.339 , pp. 89-91
- Braegger, C.P.¹ Nicholls, S.² Murch, S.H.³ Stephens, S.⁴ MacDonald, T.T.⁵

4
- 0030981088
- Tumour necrosis factor and Crohn's disease
- (1997) Gut , vol.40 , pp. 443-448
- Van Deventer, S.J.¹

5
- 0033125226
- Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
- (1999) Inflamm Bowel Dis , vol.5 , pp. 119-133
- Sandborn, W.J.¹ Hanauer, S.B.²

6
- 0030954732
- A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
- Crohn's Disease cA2 Study Group
- (1997) N Engl J Med , vol.337 , pp. 1029-1035
- Targan, S.R.¹ Hanauer, S.B.² Van Deventer, S.J.³ Mayer, L.⁴ Present, D.H.⁵ Braakman, T.⁶ DeWoody, K.L.⁷ Schaible, T.F.⁸ Rutgeerts, P.J.⁹

7
- 0033529049
- Infliximab for the treatment of fistulas in patients with Crohn's disease
- (1999) N Engl J Med , vol.340 , pp. 1398-1405
- Present, D.H.¹ Rutgeerts, P.² Targan, S.³ Hanauer, S.B.⁴ Mayer, L.⁵ Van Hogezand, R.A.⁶ Podolsky, D.K.⁷ Sands, B.E.⁸ Braakman, T.⁹ DeWoody, K.L.¹⁰ Schaible, T.F.¹¹ Van Deventer, S.J.¹²

8
- 0032833517
- Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
- (1999) Gastroenterology , vol.117 , pp. 761-769
- Rutgeerts, P.¹ D'Haens, G.² Targan, S.³ Vasiliauskas, E.⁴ Hanauer, S.B.⁵ Present, D.H.⁶ Mayer, D.H.⁷ Van Hogezand, R.A.⁸ Braakman, T.⁹ DeWoody, K.L.¹⁰ Schaible, T.F.¹¹ Van Deventer, S.J.H.¹²

9
- 0027255950
- Humanized antibodies
- (1993) Immunol Today , vol.14 , pp. 243-246
- Winter, G.¹ Harris, W.J.²

10
- 0029162562
- Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses
- (1995) Immunology , vol.85 , pp. 668-674
- Stephens, S.¹ Emtage, S.² Vetterlein, O.³ Chaplin, L.⁴ Bebbington, C.⁵ Nesbitt, A.⁶ Sopwith, M.⁷ Athwal, D.⁸ Novak, C.⁹ Bodmer, M.¹⁰

11
- 0031043778
- Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease
- (1997) Lancet , vol.349 , pp. 521-524
- Stack, W.A.¹ Mann, S.D.² Roy, A.J.³ Heath, P.⁴ Sopwith, M.⁵ Freeman, J.⁶ Holmes, G.⁷ Long, R.⁸ Forbes, A.⁹ Kamm, M.A.¹⁰

12
- 0017227303
- Development of a Crohn's disease activity index
- National Cooperative Crohn's Disease Study
- (1976) Gastroenterology , vol.70 , pp. 439-444
- Best, W.R.¹ Becktel, J.M.² Singleton, J.W.³ Kern, F.⁴

13
- 0028047268
- Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
- Canadian Crohn's Relapse Prevention Trial Study Group
- (1994) Gastroenterology , vol.106 , pp. 287-296
- Irvine, E.J.¹ Feagan, B.² Rochon, J.³ Archambault, A.⁴ Fedorak, R.N.⁵ Groll, A.⁶ Kinnear, D.⁷ Saibil, F.⁸ McDonald, J.W.⁹

14
- 0000047257
- A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human antibody to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease
- (2000) Gastroenterology , vol.118 , pp. A655
- Feagan, B.G.¹ Sandborn, W.J.² Baker, J.P.³ Cominelli, F.⁴ Sutherland, L.R.⁵ Elson, C.D.⁶ Salzberg, B.⁷ Archambault, A.⁸ Bernstein, C.N.⁹ Lichtenstein, G.R.¹⁰ Heath, P.K.¹¹ Hanauer, S.B.¹²

15
- 14744302567
- Centocor Inc., Malvern, PA, prescribing information
- (1999) Remicade (infliximab)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.